MAY 22, 2020
Grants Awarded 

Extramurally funded research grants awarded to Rogel Cancer Center members

Program Key:
CB - Cancer Biology; CG - Cancer Genetics; CHI - Cancer Hematopoiesis and Immunology; DT - Developmental Therapeutics; HBO - Health Behavior and Outcomes; CEP - Cancer Epidemiology and Prevention; TACR - Translational and Clinical Research
In the spotlight
From Translational and Clinical Research and Developmental Therapeutics
Multi-PI, inter-programmatic, $2.1M R01 awarded by the National Cancer Institute (NCI) to Theodore Lawrence, M.D., Ph.D., FASTRO, FASCO, and Mukesh Nyati, Ph.D., for “Development of a first-in-class mEGFR dimerization inhibitor"
From Cancer Biology
The NCI awarded a $2.5M U01 to Trachette Jackson , Ph.D. for Multiscale Computational Models Guided By Emerging Cellular Dynamics Quantification For Predicting Optimum Immune Checkpoint And Targeted Therapy Schedules"
Costas Lyssiotis, Ph.D., was awarded a $2M R01 from the NCI for "Stromal metabolism promotes therapeutic resistance in pancreatic cancer"
Other $100K+ Grants Awarded in April
Other NIH

Anna Mapp, Ph.D. : NIGMS R35 ($2.2M) “Probing transcriptional activation at the molecular level” (DT)

Brittany Morgan, Ph.D. (mentor: Anna Mapp, Ph.D. ): NIGMS F32 ($130K) "Molecular Recognition Frameworks for Fuzzy Protein-Protein Interactions" (DT)  

Alexey Nesvizhskii, Ph.D. : NIGMS R01 SubK University of Chicago ($280K) “Systematic screening for new histone marks and studying their epigenetic function” (CB)
Please forward this message to your fellow cancer center colleagues.
M-LINE 800-962-3555 | BLOG